pDRM166 LKB (Luciferase mKate2 Blast) Citations (1)

Originally described in: Selective inhibition of CDK9 in triple negative breast cancer.
Mustafa EH, Laven-Law G, Kikhtyak Z, Nguyen V, Ali S, Pace AA, Iggo R, Kebede A, Noll B, Wang S, Winter JM, Dwyer AR, Tilley WD, Hickey TE Oncogene. 2023 Nov 24. doi: 10.1038/s41388-023-02892-3. PubMed Journal

---

Articles Citing pDRM166 LKB (Luciferase mKate2 Blast)

Articles
Cancer cells transfer invasive properties through microRNAs contained in collagen tracks. Rouyer L, Normand L, Richard E, Allain N, Giraud J, Di-Tommaso S, Dourthe C, Raymond AA, Dupuy JW, Moreau K, Iggo R, MacGrogan G, Dugot-Senant N, Bouter A, Tan S, Favereaux A, Moreau V, Luco RF, Ros M, Saltel F. Cell Rep. 2025 Dec 23;44(12):116725. doi: 10.1016/j.celrep.2025.116725. Epub 2025 Dec 10. PubMed

If you have published an article using this material, please email us at to have your article added to this page.